Discovery of New Selective Human Aldose Reductase Inhibitors through Virtual Screening Multiple Binding Pocket Conformations

By Ling Wang, Qiong Gu, Xuehua Zheng, Jiming Ye, Zhihong Liu, Jiabo Li, Xiaopeng Hu, A. Hagler, Jun Xu. 2013

68 citations recorded by the source corpus.

Subfields: Cell Biology, Molecular Biology, Pharmacology, Computational Chemistry & Drug Discovery

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Glaucius Oliva
2. L. Ferreira
3. Ricardo N Dos Santos
4. Maria Batool
5. Adriano Defini Andricopulo
6. Sangdun Choi
7. Bilal Ahmad

In Pharmacology

1. Maria Batool
2. Adriano Defini Andricopulo
3. Sangdun Choi
4. Bilal Ahmad

In Computational Chemistry & Drug Discovery

1. Glaucius Oliva
2. Maria Batool
3. Adriano Defini Andricopulo
4. L. Ferreira
5. Sangdun Choi
6. Ricardo N Dos Santos
7. Bilal Ahmad
8. Giulio Rastelli

Citations in the corpus

• Molecular Docking and Structure-Based Drug Design Strategies (2015, methodology): “Currently, epalrestat (Kinedak ® ) is marketed in Japan as an ALR2 inhibitor for the treatment of diabetic neuropathy [219].”
• A Structure-Based Drug Discovery Paradigm (2019, methodology): “VS is classified into two major types: ligand-based VS (LBVS) and SBVS.”